2020 Annual Meeting On-Demand: Full Access (Sat-Mon Sessions)


By far the best value to watch all the educational sessions from the 2020 AABB Annual Meeting and earn continuing education credit. This package includes 79 sessions which are eligible for up to:

  • 81 General Participation credits
  • 72 Continuing Medical Education credits (CME) for physicians
  • 81 California Lab Personnel, Florida Lab Personnel or California Nurse contact hours.

If purchasing each session individually the cost is $1,570/$1,960 (member/nonmember). Access is available through December 31, 2022 so purchase this package today.

Residents/Fellows/Students – AABB is pleased to offer a reduced rate of $149/$199 (that’s more than $350 off the list price). Simply email a signed a letter from your institution/Program Director and/or current student transcript verifying your status to eLearning@aabb.org.

Virtual meeting attendees - AABB will extend the discounted price of $249/$299 (member/nonmember) for purchase of this package. Contact eLearning@aabb.org to receive a promocode to use to register. 

Purchase of this package includes the on-demand recording and a downloadable MP3 audio file for each session. Presentation handouts are not available/included.

Members: $499.00
Standard: $599.00

Products

AM20-32: Late-breaking Oral Abstract Session

Preview Available

AM20-32: Late-breaking Oral Abstract Session

Oct 4, 2020 7:15pm ‐ Oct 4, 2020 8:15pm
Expiration Date: Dec 31, 2022

Credits: None available.

Oral abstract session on Late-breaking Oral abstracts

Speaker(s):
Standard: $25.00
Members: $20.00

AM20-33: COVID-19 Convalescent Plasma (CCP) -- The Regulatory Landscape

Preview Available

AM20-33: COVID-19 Convalescent Plasma (CCP) -- The Regulatory Landscape

Oct 5, 2020 10:00am ‐ Oct 5, 2020 11:00am
Expiration Date: Dec 31, 2022

Credits: None available.

During this live Q&A session, FDA’s Peter Marks and Nicole Verdun will answer questions about the regulatory framework for COVID-19 Convalescent Plasma (CCP). We will be taking live questions during the session and will try to get to as many of them as possible. 

Topics for discussion include:

- Timeline for implementation of the EUA.
- FDA’s use of temporary enforcement discretion .
- An update on the testing and labeling collections as high-titer or low-titer.
- Inventory management options such as retesting units collected under the National Expanded Access 

Program for use under the EUA or for shipment to the Surge Capacity Storage

Speaker(s):
  • Dr. Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research, FDA
  • Dr. Nicole Verdun, MD, Director, Office of Blood Research and Review, FDA
Standard: $25.00
Members: $20.00

AM20-34: New Therapeutic Options for Patients with Sickle Cell Disease & Their Effect on the Transfusion Service

Preview Available

AM20-34: New Therapeutic Options for Patients with Sickle Cell Disease & Their Effect on the Transfusion Service

Oct 5, 2020 10:00am ‐ Oct 5, 2020 11:00am
Expiration Date: Dec 31, 2022

Credits: None available.

Sickle cell disease (SCD) is an inherited condition that affects about 100,000 individuals in the United States. This disorder is familiar to the transfusion medicine professionals (Physicians; Technologists) since it relies heavily on transfusion of blood products - either via simple transfusion or RBC exchange. In recent years (2017-2019), newer potentially disease-modifying options were identified and approved by the FDA for use including l-glutamin, anyipolomerization agents (voxelotor) and P-selectin inhibitors (crizanlizumab). Furthermore, gene therapy might be a real option for cure of the disease. This session will concentrate on the education of Transfusion Medicine professionals on these advances and their possible implications for clinical practice and subsequent potential effect on the transfusion service.

Speaker(s):
Standard: $25.00
Members: $20.00

AM20-35: Oral Abstract Session -- Pediatrics and Obstetrics

Preview Available

AM20-35: Oral Abstract Session -- Pediatrics and Obstetrics

Oct 5, 2020 10:00am ‐ Oct 5, 2020 11:00am
Expiration Date: Dec 31, 2022

Credits: None available.

Oral abstract session on Pediatrics and Obstetrics

Speaker(s):
Standard: $25.00
Members: $20.00

AM20-36: Oral Abstract Session -- COVID-19

Preview Available

AM20-36: Oral Abstract Session -- COVID-19

Oct 5, 2020 11:15am ‐ Oct 5, 2020 12:15pm
Expiration Date: Dec 31, 2022

Credits: None available.

Oral abstract session on COVID-19

Speaker(s):
Standard: $25.00
Members: $20.00

AM20-37: Temas Relevantes En El Area De Medicina Transfusional y Manejo Eficiente De Los Recursos Disponibles

Preview Available

AM20-37: Temas Relevantes En El Area De Medicina Transfusional y Manejo Eficiente De Los Recursos Disponibles

Oct 5, 2020 11:15am ‐ Oct 5, 2020 12:15pm
Expiration Date: Dec 31, 2022

Credits: None available.

Este taller se dividira en dos secciones, en la primera parte se revisara el tema de hemorragia masiva y protocolos para controlar el sangramiento. Se discutira un caso clinico de un paciente con hemorragia y alloanticuerpos , el cual requiere una cantidad elevada de transfusiones, negativa para antigenos communmente presentes en la mayoria de los donantes. Veran tecnicas y protocolos usados en el laboratorio de inmunohematologia y el hospital para garantizar la disponibilidad de sangre en estos casos complejos. En la segunda parte del programa, se revisa el porque y la necesidad de la globalizacion de los servicios de banco de sangre y la eficiencia de este modelo en la preparacion de componentes y distribucion de sangre a los hospitals para asegurar la disponibilidad apropiada de los productos sanguineos.

This workshop will be divided into two sections, in the first part we will review the topic of massive hemorrhage and protocols to control bleeding. A clinical case of a patient with hemorrhage and alloantibodies will be discussed, which requires a high amount of transfusions, negative for antigens commonly present in the majority of donors. You will see techniques and protocols used in the immunohematology laboratory and the hospital to ensure blood availability in those complex cases. In the second part of the program, the reasoning and the need for the globalization of blood bank services and the efficiency of this model in the preparation of components and distribution of blood to hospitals to ensure the appropriate availability of products is reviewed.

Speaker(s):
Standard: $25.00
Members: $20.00

AM20-38: The Thin Line Between Advancement or Exploitation…the Role of the “Super Donor” in Allogeneic Cell Therapy

Preview Available

AM20-38: The Thin Line Between Advancement or Exploitation…the Role of the “Super Donor” in Allogeneic Cell Therapy

Oct 5, 2020 11:15am ‐ Oct 5, 2020 12:15pm
Expiration Date: Dec 31, 2022

Credits: None available.

Discover why reliance on a small subset of “super donors” could introduce risk and ignite ethical considerations for cell and gene therapy companies seeking sustainable growth and scalability.

Speaker(s):
Standard: $25.00
Members: $20.00

AM20-39: Practical Hemostasis in Transfusion Medicine: Test Interpretation & Therapeutic Strategies for Coagulation Conundrums

Preview Available

AM20-39: Practical Hemostasis in Transfusion Medicine: Test Interpretation & Therapeutic Strategies for Coagulation Conundrums

Oct 5, 2020 2:30pm ‐ Oct 5, 2020 3:30pm
Expiration Date: Dec 31, 2022

Credits: None available.

On a day-to-day basis, transfusion medicine and apheresis practitioners are asked to play critical and often acute care roles as consultants for complex issues related to hemostasis and thrombosis. The intricacy of coagulation assays and the blood bank and pharmaceutical tools available for managing bleeding disorders have all expanded dramatically over the past 5-10 years. Therefore, in order to provide accurate hemostasis/thrombosis consultation, providers must have an up-to-date understanding of common coagulation assays and how their results inform transfusion and apheresis management. The aim of this session is to familiarize practitioners with common coagulation problems, with an emphasis on test interpretation to improve consultation and management of bleeding/clotting disorders from the transfusion medicine and apheresis perspectives. We will focus on three critical areas of hemostasis/thrombosis and intend to: 1) familiarize practitioners with the current concepts of congenital bleeding disorders, with a particular emphasis on diseases that are primarily managed via blood components (e.g., Factor V deficiency, FXI deficiency) and inform learners on how coagulation assays can be used to guide therapy for these disorders, 2) discuss the clinical problem of lupus anticoagulants (LACs), with an emphasis on demystifying the highly complicated testing platforms associated with these disorders and to highlight roles blood bank and apheresis services play in managing complications of LACs, and 3) examine the problem of cardiac surgery-associated bleeding, including exploring its pathophysiology, investigating acute care assays which may be helpful in its assessment, and recommending practical transfusion strategies for acquired platelet function abnormalities.

Speaker(s):
Standard: $25.00
Members: $20.00

AM20-40: Platelet Inventory Management for Transfusion Services

Preview Available

AM20-40: Platelet Inventory Management for Transfusion Services

Oct 5, 2020 2:30pm ‐ Oct 5, 2020 3:30pm
Expiration Date: Dec 31, 2022

Credits: None available.

Blood product inventory management is essential for improving patient care and mitigating the increasing cost of healthcare. On September 30, 2019, the US FDA published a Guidance for Industry titled “Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion.” This guidance offers 9 options for reducing the risk of bacterial contamination of platelets, but may decrease rather than increase platelet availability. In this setting, effective platelet inventory management (PIM) is more important than ever.

Nancy Dunbar will review evidence based platelet transfusion triggers, examine methods for prospective order auditing, and explore strategies for PIM during times of shortage.

Tho Pham will cover how to use big data and computer modeling to enhance PIM. While platelet usage can be highly variable, big data can be mined to identify relationships to build a statistical model capable of forecasting platelet demand. This analysis can be used to guide platelet ordering to decrease expiration, reduced wastage, and avoid shortages.

Neil Shah will address the role of clinical decision support (CDS) for platelet ordering to improve PIM. Aspects of implementing a successful CDS program, starting from clinical acceptance of best-practice evidence and establishing local guidelines, to building and implementing a successful CDS program will be described.

Speaker(s):
  • Dr. Nancy M. Dunbar, MD, Associate Professor for the Dept. of Pathology and Lab Medicine; Associate Medical Director of Transfusion Service and Medical Director of Blood Bank, Dartmouth-Hitchcock Medical Center
  • Tho D. Pham, MD, Clinical Assistant Professor; Chief Medical Officer, Stanford University School of Medicine
  • Dr. Neil Shah, MD, Stanford University Medical Center
Standard: $25.00
Members: $20.00

AM20-41: Engineered Microphysiological Systems -- AABB/TERMIS Joint Session

Preview Available

AM20-41: Engineered Microphysiological Systems -- AABB/TERMIS Joint Session

Oct 5, 2020 2:30pm ‐ Oct 5, 2020 3:30pm
Expiration Date: Dec 31, 2022

Credits: None available.

Presented in collaboration with Be The Match BioTherapies® 

Microphysiological systems, also often referred to as “organ-on-a-chip," are two- or three-dimensional constructs using human cells designed to model the spatial, chemical, structural, and physiological elements of in vivo cellular environments. This is currently one of the hottest research areas in the development of translational applications. Faculty in this session will explore various applications including drug screening and toxicology, tumor models for cancer diagnosis, and models for human development and diseases.

Speaker(s):
Standard: $25.00
Members: $20.00
Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content